Skip to main content
C

Curada

Curada provides an AI-powered digital platform for pharmacological extinction therapy, utilizing The Sinclair Method to retrain the brain's reward pathways and reduce alcohol cravings. The platform offers a self-directed, science-backed solution for individuals seeking to alter their alcohol consumption habits through virtual assessments, prescription management, and AI-driven support.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Individuals seeking to modify their relationship with alcohol often face treatment paradigms that are not aligned with neurobiological principles of learning and reward. Traditional approaches can be rigid, leading to suboptimal outcomes for those who do not respond to abstinence-based methods.

Solution

Curada offers an AI-powered digital platform that facilitates pharmacological extinction therapy, leveraging The Sinclair Method to retrain the brain's reward pathways. This approach targets endorphin receptor modulation to reduce alcohol cravings and promote the formation of new behavioral patterns. The platform provides a self-directed, science-backed solution designed for individuals seeking to alter their alcohol consumption habits. It integrates virtual assessments, prescription management through licensed providers, and AI-driven support to guide users through the process.

Target Audience

The primary users are individuals seeking a science-based, self-directed approach to modify their alcohol consumption, particularly those who may not find abstinence-only models effective.

Features

  • AI-powered digital platform for pharmacological extinction therapy
  • Utilizes The Sinclair Method for neurobiological retraining of reward systems
  • Endorphin receptor modulation to reduce cravings and foster new behavioral patterns
  • Virtual assessment and two-week drink diary for provider evaluation
  • Prescription issuance by licensed providers for eligible candidates
  • Rx Enhanced Learning feature utilizing a post-dose receptor-sensitive window
  • Asynchronous chat functionality for user-provider communication
  • Peer companion matching for collaborative progress tracking and shared insights
  • Secure, encrypted data storage with a commitment to user privacy
  • Online, on-demand protocol accessible without traditional clinic visits
This profile is AI-generated and may contain inaccuracies.